Sobi and Savient Pharmaceuticals Announce Co-Promotion Agreement for Kineret® (anakinra) in the U.S.

Sobi and Savient Pharmaceuticals Announce Co-Promotion Agreement for Kineret® (anakinra) in the U.S.

[at noodls] – More news 2013-02-19 Sobi Press Release on February 19, 2013, in PDF format CONTACT: Swedish Orphan Biovitrum (Sobi) AB Alan Raffensperger Chief Operating Officer +46 8 697 20 90 Savient Pharmaceuticals, … more

View todays social media effects on SVNT

View the latest stocks trending across Twitter. Click to view dashboard

See who Savient is hiring next, click here to view

Share this post